Wealth Enhancement Advisory Services’s Exact Sciences EXAS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,481	Closed	-$1.2M	–	4171
2026 Q1	$1.2M	Sell	11,481 -81,585	-88%	-$8.4M	﹤0.01%	1682
2025 Q4	$9.46M	Buy	93,066 +29,415	+46%	+$2.36M	0.01%	715
2025 Q3	$3.68M	Buy	63,651 +1,610	+3%	+$80.4K	0.01%	1117
2025 Q2	$3.31M	Buy	62,041 +22,351	+56%	+$1.14M	0.01%	1100
2025 Q1	$1.72M	Buy	39,690 +555	+1%	+$28.1K	﹤0.01%	1324
2024 Q4	$2.2M	Buy	39,135 +3,434	+10%	+$214K	﹤0.01%	1135
2024 Q3	$2.43M	Sell	35,701 -2,521	-7%	-$142K	0.01%	971
2024 Q2	$1.61M	Buy	38,222 +2,413	+7%	+$133K	﹤0.01%	1076
2024 Q1	$2.47M	Buy	35,809 +498	+1%	+$31.5K	0.01%	873
2023 Q4	$2.61M	Buy	35,311 +1,162	+3%	+$76.2K	0.01%	809
2023 Q3	$2.33M	Buy	+34,149	New	+$2.9M	0.01%	810

Wealth Enhancement Advisory Services's EXAS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Exact Sciences (EXAS) in Q2 2026, closing a stake of 11,481 shares — an estimated $1.2M sold.

Wealth Enhancement Advisory Services first reported a position in EXAS in Q3 2023 and held it in 11 quarters. The position peaked at $9.46M in Q4 2025. 0 funds tracked by Wall St. Rank hold EXAS as of Q2 2026.

Wealth Enhancement Advisory Services reported no remaining Exact Sciences position as of Q2 2026 after selling out during the quarter.
Wealth Enhancement Advisory Services sold 11,481 Exact Sciences shares in Q2 2026, an estimated $1.2M.
Wealth Enhancement Advisory Services first reported a position in Exact Sciences in Q3 2023 and held it in 11 quarters.
Wealth Enhancement Advisory Services's Exact Sciences position peaked at $9.46M in Q4 2025.
0 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.